Press-release for stocks for turning point therapeutics, inc. for bmy

Bristol Myers Squibb Reports Third Quarter Financial Results for 2023
Published: 2023-10-26 (Crawled : 13:00) - biospace.com/
XYF | $3.78 0.0% 5.6K

| -3.57% | O: -3.19% H: 4.87% C: 4.87%
BMY | $48.93 1.3% 0.0% 10M

| -13.57% | O: -4.68% H: 2.46% C: -1.83%
MRTX | $58.7 -0.17% 0.34% 0

| 6.54% | O: 0.16% H: 0.47% C: 0.2%
financial results

Bristol Myers Squibb Reports Third Quarter Financial Results for 2022
Published: 2022-10-26 (Crawled : 05:00) - biospace.com/
TSVT | $4.52 -2.59% -2.65% 610K

| -69.45% | O: 0.37% H: 5.32% C: 4.04%
BMY | $48.93 1.3% 0.0% 10M

| -32.76% | O: 0.44% H: 2.9% C: 1.86%
financial

Bristol Myers Squibb Completes Acquisition of Turning Point Therapeutics, Expanding Precision Oncology Portfolio
Published: 2022-08-17 (Crawled : 13:20) - biospace.com/
BMY | $48.93 1.3% 0.0% 10M

| -33.99% | O: -0.3% H: 1.45% C: 0.88%
acquisition

| -34.35% | O: -0.23% H: 1.0% C: -0.31%
TPTX | $76.01 -0.03%

| 0.75% | O: 0.75% H: 0.0% C: 0.0%
acquisition clearance therapeutics germany

Bristol Myers Squibb Reports Second Quarter Financial Results for 2022
Published: 2022-07-27 (Crawled : 12:00) - biospace.com/
BMY | $48.93 1.3% 0.0% 10M

| -33.55% | O: -1.68% H: 3.58% C: 3.34%
TPTX | $76.01 -0.03%

| 1.36% | O: -0.01% H: 0.28% C: 0.11%
IMTX | $10.19 -0.68% -0.69% 180K

| -9.16% | O: 0.53% H: 2.04% C: 0.27%

Bristol Myers Squibb Announces Extension of Turning Point Tender Offer
Published: 2022-07-19 (Crawled : 12:00) - biospace.com/
BMY | $48.93 1.3% 0.0% 10M